Arvinas (ARVN) Capital Expenditures (2017 - 2026)
Arvinas (ARVN) posted Capital Expenditures of $200,000 for Q2 2026, down 83.3% from $1.2 million a year earlier and down 84.6% from the prior quarter.
Powered by 
Analysis
Arvinas (ARVN) Capital Expenditures (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Arvinas was $1.8 million, down 30.8% year-over-year; for FY2025, it was $1.9 million, up 5.6% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of -21.6% (FY2020 to FY2025).
- In prior years, Arvinas' Capital Expenditures was $1.8 million in FY2024 (-37.9%), $2.9 million in FY2023 (-57.4%), $6.8 million in FY2022 (+44.7%) and $4.7 million in FY2021 (-26.6%).
- Quarterly Capital Expenditures has run from a low of $100,000 in Q4 2023 to a high of $2.2 million in Q3 2022 over five years.
- On a year-over-year basis, Capital Expenditures increased in four of the last eight quarters, with growth averaging 69.7%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q1 2025, with growth of 300.0%; the weakest was Q4 2023, with a decline of 90.9%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $1.3 million (Q1 2026), $200,000 (Q4 2025) and $100,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Arvinas | 505.42 Mn | -2.15 Bn | - | 200,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 200,000.00 |
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 300,000.00 |
| Sep 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 600,000.00 |
| Mar 31, 2023 | 1.10 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | 2.20 Mn |
| Jun 30, 2022 | 1.40 Mn |
| Mar 31, 2022 | 2.10 Mn |
| Dec 31, 2021 | 1.90 Mn |
| Sep 30, 2021 | 1.30 Mn |
API Access
Arvinas Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ARVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();